Axitinib, cabozantinib, or everolimus in the treatment of prior sunitinib-treated patients with metastatic renal cell carcinoma: results of matching-adjusted indirect comparison analyses

Proskorovsky, I; Benedict, A; Negrier, S; Bargo, D; Sandin, R; Ramaswamy, K; Desai, J; Cappelleri, JC; Larkin, J

Proskorovsky, I (reprint author), Evidera, 7575 Trans Canada Highway,Suite 404, Montreal, PQ H4R 1V6, Canada.

BMC CANCER, 2018; 18 ():